WWOX and prostate carcinoma: However, low or decreased expression and aberrant transcription of WWOX has been reported in several types of cancer, including nonsmall cell lung cancer (85%), prostate cancer (84%), breast cancer (63%), and oral cancer (40%) [19–24].